The Valley Desk

Clinical trial reportAmerican journal of hematologyPublished

Roxadustat versus placebo for patients with lower-risk myelodysplastic syndrome: MATTERHORN phase 3, double-blind, randomized controlled trial

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Pennsylvania Hospital, with Penn Medicine linked by the institution reference. Affiliation source

Publication record

Type
Clinical trial report
Venue
American journal of hematology
Published
Subject terms
Humans; Myelodysplastic Syndromes; Isoquinolines; Glycine; Treatment Outcome; Erythrocyte Transfusion; Double-Blind Method; Adult; Aged; Aged, 80 and over; Middle Aged; Female
PubMed ID
38884137
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal